167 
1 to evaluate the need and feasibility for P 3 -level physical 
2 containment facilities. The need and feasibility for a 
3 facility was soon established, and a successful proposal 
4 for matching funds was made to NIH. A three-member users 
5 committee was proposed to oversee the actual day-to-day 
6 operation of the facility, with this committee to be 
7 closely monitored by the institutional committee. Again, 
8 my interactions with the institutional committee in my 
g endeavor to obtain a P 3 facility reinforces my strong 
10 belief that such committees will continue to responsibly 
11 carry out their assigned duties under the revised guidelines. 
12 I have the pleasure of knowing many of the 
13 scientists who are carrying on highly significant research 
14 projects using recombinant DNA techniques, some of whom 
15 have been involved in the formation of the original 
16 guidelines and the current proposed revised guidelines. 
17 I count several of these investigators as very good 
18 friends. As a group, they are highly motivated, highly 
19 intelligent, and intellectually honest scientists, who 
20 are respected in their communities. I find, perhaps not 
21 unexpectedly, that they are also quite gentle people. 
22 In addition, those whom I have been privileged 
23 to know in family situations have always demonstrated a 
24 deep affection for their spouses and their children. 
25 Knowing these people as I do, it is inconceivable to me 
[259] 
